Clinical Trial Update: Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors [Phase 4]

View source ↗

Summary

Phase 4 study comparing Dotarem-enhanced MRI to Gadovist/Gadavist-enhanced MRI for diagnosing brain tumors; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• DOTAREM (Gadoterate meglumine)
• Gadovist (gadobutrol)

Snippet

Sponsor: Guerbet | Conditions: Primary Brain Tumor | Phase 4 | Status: COMPLETED | Results posted: 2016-10-25